Overview

WD-1603 PK Study Under Fasting and Fed Conditions in Healthy Subjects

Status:
Recruiting
Trial end date:
2021-02-13
Target enrollment:
Participant gender:
Summary
The Phase 1 PK study is planned to evaluate the food effect on WD-1603 pharmacokinetics
Phase:
Phase 1
Details
Lead Sponsor:
Hong Kong WD Pharmaceutical Co., Limited
Treatments:
Carbidopa
Levodopa